Crossmark

The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells

Crossref DOI link: https://doi.org/10.1186/s12935-018-0527-x

Published Online: 2018-03-01

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Silveira, Elaine

Cavalcante, Isadora Pontes

Kremer, Jean Lucas

de Mendonça, Pedro Omori Ribeiro

Lotfi, Claudimara Ferini Pacicco https://orcid.org/0000-0002-9881-7099
Funding

Funding for this research was provided by:

FAPESP-São Paulo State Research Foundation (2011/07656-3, 2015/014199-9)

Capes-Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
More Information

Article History

Received: 28 September 2017

Accepted: 19 February 2018

First Online: 1 March 2018

Document is current

Any future updates will be listed below